journal article·2025-07-04Open access

Fluorescence Anisotropy for Detailed Analysis of Doxorubicin Loading into DNA Origami Nanocarriers for Drug Delivery

Ekaterina S. Lisitsyna, Anna Klose, Elina Vuorimaa-Laukkanen, Heini Ijäs, Tatu Lajunen, Klaus Suhling, Veikko Linko, Timo Laaksonen

ACS Applied Nano Materials· Volume 8· Issue 26

Abstract

Owing to doxorubicin's high DNA binding affinity, doxorubicin-loaded DNA origami nanostructures (DOX-DONs) are promising nanocarriers against cancer. However, understanding the interactions between doxorubicin (DOX) and DNA origami nanostructures (DONs) is important to ensure the quality of DOX-DONs. This interaction is often taken for granted and the influence of DOX loading conditions is poorly characterized. Exploiting the inherent fluorescence of DOX, steady-state and time-resolved fluorescence anisotropy spectroscopy techniques are used for characterizing nondestructively the binding between DOX and DONs, and the purity of the formed complexes. The difference in fluorescence anisotropy between free DOX and DOX-DONs confirms the DOX-DON complex formation. Further, at loading ratios of DOX to DNA base pairs >0.5, homo-Förster resonance energy transfer (homo-FRET) between closely packed DOX molecules is observed. Moreover, time-resolved anisotropy reveals DOX aggregation on DONs at high loading ratios >1. For loading ratios >0.1, spin-filtration to remove excess free DOX is efficient and necessary, though at loading ratios >1 some DOX aggregates remain attached to the DONs. In summary, fluorescence anisotropy analysis provides more detailed information and insight into DOX-DONs compared to the regularly used fluorescence intensity-based characterization methods, and these results can help designing more efficient and safer DNA intercalator-based nanocarriers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Biosensors and Analytical Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Chemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University, Korkeakoulunkatu 8, 33720 Tampere, Finland

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5, 00790 Helsinki, Finland

Biohybrid Materials, Department of Bioproducts and Biosystems

Aalto University

School of Pharmacy

University of Eastern Finland, Yliopistonranta 1 C

Department of Physics

King’s College London

Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia

Funding

Emil Aaltosen S??ti? · European Research Council · Sigrid Jus?liuksen S??ti? · Research Council of Finland · Jane ja Aatos Erkon S??ti? · Horizon 2020 Framework Programme · Biotechnology and Biological Sciences Research Council · Suomen Kulttuurirahasto

References (70)

Show source-provided references
1. 10.1016/0022-5193(82)90002-910.1016/0022-5193(82)90002-9 ↗
2. 10.1038/nature0458610.1038/nature04586 ↗
3. 10.1038/nature0801610.1038/nature08016 ↗
4. 10.1038/s43586-020-00009-810.1038/s43586-020-00009-8 ↗
5. 10.1002/anie.20191639010.1002/anie.201916390 ↗
6. 10.1021/nn503513p10.1021/nn503513p ↗
7. 10.1002/anie.20180289010.1002/anie.201802890 ↗
8. 10.1002/smll.20230193510.1002/smll.202301935 ↗
9. 10.1002/smll.20210806310.1002/smll.202108063 ↗
10. 10.1126/science.121408110.1126/science.1214081 ↗
11. 10.1038/s41563-020-0793-610.1038/s41563-020-0793-6 ↗
12. 10.1002/anie.20200984210.1002/anie.202009842 ↗
13. 10.1038/nbt.407110.1038/nbt.4071 ↗
14. 10.1021/nn302266210.1021/nn3022662 ↗
15. 10.1021/ja304263n10.1021/ja304263n ↗
16. 10.1021/nn502058j10.1021/nn502058j ↗
17. 10.1016/S0006-2952(98)00307-410.1016/S0006-2952(98)00307-4 ↗
18. 10.4103/0973-1482.13926710.4103/0973-1482.139267 ↗
19. 10.1021/acs.nanolett.7b0481210.1021/acs.nanolett.7b04812 ↗
20. 10.1002/anie.20180945210.1002/anie.201809452 ↗
21. 10.1021/jp411429g10.1021/jp411429g ↗
22. 10.1039/C8CP06776G10.1039/C8CP06776G ↗
23. 10.1093/nar/gkab09710.1093/nar/gkab097 ↗
24. 10.1016/j.ijpharm.2013.06.05810.1016/j.ijpharm.2013.06.058 ↗
25. 10.1039/C7TB03223D10.1039/C7TB03223D ↗
26. 10.1039/C7NR02222K10.1039/C7NR02222K ↗
27. 10.3390/molecules2201001710.3390/molecules22010017 ↗
28. 10.1021/acs.jpcc.1c0989210.1021/acs.jpcc.1c09892 ↗
29. 10.1016/j.bpj.2019.04.01610.1016/j.bpj.2019.04.016 ↗
30. 10.1529/biophysj.108.13337110.1529/biophysj.108.133371 ↗
31. 10.1021/bm401579210.1021/bm4015792 ↗
32. 10.1002/352760024810.1002/3527600248 ↗
33. 10.1002/cphc.20100083310.1002/cphc.201000833 ↗
34. 10.1021/cr900267p10.1021/cr900267p ↗
35. 10.1039/b920242k10.1039/b920242k ↗
36. Vogel S. S. · 2009
37. 10.1016/j.saa.2017.12.02510.1016/j.saa.2017.12.025 ↗
38. 10.1088/0957-0233/27/4/04500710.1088/0957-0233/27/4/045007 ↗
39. 10.1088/2050-6120/1/2/02500110.1088/2050-6120/1/2/025001 ↗
40. 10.1016/j.ymeth.2010.06.00110.1016/j.ymeth.2010.06.001 ↗
41. 10.1016/j.aca.2020.05.06110.1016/j.aca.2020.05.061 ↗
42. 10.3390/s2024713210.3390/s20247132 ↗
43. 10.1002/adma.20180567110.1002/adma.201805671 ↗
44. 10.1021/acs.analchem.2c0153210.1021/acs.analchem.2c01532 ↗
45. 10.1073/pnas.090191310610.1073/pnas.0901913106 ↗
46. 10.1016/j.bpj.2020.11.227510.1016/j.bpj.2020.11.2275 ↗
47. 10.1007/978-0-387-46312-410.1007/978-0-387-46312-4 ↗
48. 10.1016/j.jsb.2003.10.01310.1016/j.jsb.2003.10.013 ↗
49. 10.1021/ja803407t10.1021/ja803407t ↗
50. 10.1016/S0006-3495(95)80030-510.1016/S0006-3495(95)80030-5 ↗
51. 10.1364/OE.15.00693410.1364/OE.15.006934 ↗
52. 10.1039/c2cp44056c10.1039/c2cp44056c ↗
53. 10.1016/j.colsurfa.2021.12669310.1016/j.colsurfa.2021.126693 ↗
54. 10.3390/pharmaceutics1308124810.3390/pharmaceutics13081248 ↗
55. 10.1021/acs.langmuir.6b0186010.1021/acs.langmuir.6b01860 ↗
56. 10.1016/j.msec.2021.11186910.1016/j.msec.2021.111869 ↗
57. 10.1016/j.jphotobiol.2017.03.02410.1016/j.jphotobiol.2017.03.024 ↗
58. 10.1021/la403766610.1021/la4037666 ↗
59. 10.1021/j100143a05410.1021/j100143a054 ↗
60. 10.1039/C6SC03404G10.1039/C6SC03404G ↗
61. 10.1038/srep1563410.1038/srep15634 ↗
62. 10.3390/molecules2613396810.3390/molecules26133968 ↗
63. 10.1111/j.1751-1097.1998.tb09082.x10.1111/j.1751-1097.1998.tb09082.x ↗
64. 10.1002/smll.20210178010.1002/smll.202101780 ↗
65. 10.1021/acsabm.2c0011410.1021/acsabm.2c00114 ↗
66. 10.1371/journal.pone.004494710.1371/journal.pone.0044947 ↗
67. 10.1039/D2NR00311B10.1039/D2NR00311B ↗
68. 10.1016/j.nano.2007.12.00210.1016/j.nano.2007.12.002 ↗
69. 10.1039/C5PY01841B10.1039/C5PY01841B ↗
70. 10.1016/j.bpj.2019.04.01410.1016/j.bpj.2019.04.014 ↗